**Core Concept**
Anosmia, the loss of the sense of smell, is a significant clinical feature of various neurological and systemic disorders. It is often associated with damage to the olfactory epithelium in the nasal cavity or the olfactory bulb and tract in the brain.

**Why the Correct Answer is Right**
Anosmia is an early clinical feature of Parkinson's disease (PD). The exact mechanism of anosmia in PD is not fully understood, but it is thought to be related to the degeneration of the olfactory bulb and tract, which is often affected in PD. This degeneration is likely due to the accumulation of alpha-synuclein protein, a hallmark of PD pathology. Studies have shown that up to 90% of patients with PD experience some degree of olfactory impairment, making anosmia a key early diagnostic feature.

**Why Each Wrong Option is Incorrect**
**Option A:** Alzheimer's disease is primarily associated with cognitive decline and memory loss, rather than anosmia. While some patients with Alzheimer's may experience olfactory impairment, it is not a defining feature of the disease.
**Option B:** Huntington's disease is characterized by chorea, cognitive decline, and psychiatric symptoms, but anosmia is not a typical early feature.
**Option C:** Multiple sclerosis is an autoimmune disease that affects the central nervous system, but anosmia is not a primary symptom of the disease.

**Clinical Pearl / High-Yield Fact**
In addition to PD, other conditions that can cause anosmia include head trauma, viral infections (such as COVID-19), and certain medications (such as anesthetics and antidepressants).

**Correct Answer:** B.